QbD Group
    即将举办的网络研讨会

    Managing Lifecycle Complexity

    Controlling Compliance Risk and Operational Pressure Across Regulatory and Pharmacovigilance

    As pharmaceutical organizations grow and evolve, Lifecycle Management becomes increasingly difficult to control. This webinar explores how complexity develops across Regulatory Affairs and Pharmacovigilance, and how to structure activities in a more scalable and cost-efficient way.

    2026年6月25日星期四
    3 PM CEST / 1 PM GMT
    Pharmacovigilance · Regulatory Affairs
    中文

    In today's pharmaceutical environment, Lifecycle Management is no longer only a regulatory or pharmacovigilance challenge, it is an operational challenge.

    As organizations grow internationally, add products, integrate acquisitions, or expand into multiple markets, both Regulatory Affairs and Pharmacovigilance teams face increasing operational complexity. Activities become more interconnected, coordination becomes more difficult, and pressure grows to maintain compliance while controlling workload, timelines, costs, and operational risk.

    This webinar explores how these challenges develop across three common operational scenarios:

    • Integration of new product types where internal expertise is limited
    • Growing portfolios with constrained internal resources
    • Expansion into new markets with limited local knowledge or operational capacity

    For each scenario, we will connect operational complexity with its impact on variations, submissions, safety reporting, compliance oversight, and cross-functional coordination.

    The session will also highlight:

    • Loss of control — Where lifecycle execution typically starts to lose control
    • Emerging risks — What risks emerge in terms of compliance, timelines, data consistency, and operational efficiency
    • Scalable structure — How organizations can structure Lifecycle Management activities in a more scalable and cost-efficient way

    We will conclude with case studies showing how an integrated Lifecycle Management approach helped stabilize operations, reduce complexity, and improve efficiency and cost control across Regulatory and Pharmacovigilance functions.

    您将学到什么

    • How operational complexity, workload, and compliance pressure develop across Regulatory Affairs and Pharmacovigilance activities
    • How common business scenarios impact variations, submissions, safety reporting, and cross-functional coordination
    • Where Lifecycle Management activities typically become inefficient or difficult to control
    • How to improve operational efficiency while maintaining compliance and managing resource constraints
    • How integrated Regulatory and PV approaches can support more scalable and cost-efficient operating models
    • Practical lessons from real-life cases where Lifecycle Management complexity was successfully managed

    向最优秀的人学习

    演讲者

    Dr. Almudena del Castillo

    Dr. Almudena del Castillo

    Global Division Head of Drug Safety and Vigilance, QbD Group

    A Medical Doctor and Specialist in Family and Community Medicine, Almudena has built a career spanning pharmacovigilance, regulatory affairs, and drug safety across some of the industry's most prominent organisations, including Pfizer. Before joining QbD Group, she served as VP of Sales and Business Development at Pharmalex and PLG. She is currently Global Division Head of Drug Safety and Vigilance at QbD Group.

    Joanna Rapacz

    Joanna Rapacz

    RA & CMC Director and Qualified Person, QbD Group

    Joanna brings over 25 years of pharmaceutical industry experience to her role as RA & CMC Director and Qualified Person at QbD Group. Her expertise spans Regulatory Affairs, CMC strategy, GMP quality oversight, and compliance implementation, underpinned by a strong foundation in quality control and R&D. She supports pharmaceutical organisations across the full scope of development and international product authorisation.

    距离开始

    30Days
    13Hours
    49Min
    23Sec

    在此报名

    这是为您准备的吗?

    适合参加人员

    This webinar is designed for leaders and professionals responsible for Regulatory Affairs and Pharmacovigilance operations in pharmaceutical organizations facing growing operational complexity.

    Heads, Directors, and Managers of Regulatory Affairs

    Heads, Directors, and Managers of Pharmacovigilance / Drug Safety

    Regulatory Affairs professionals managing variations, submissions, renewals, and post-approval activities

    Pharmacovigilance professionals responsible for safety reporting, compliance oversight, and operational coordination

    Procurement and outsourcing managers involved in vendor selection, operational scalability, and external support models

    继续观看

    更多 Webinars

    Pharmacovigilance and Risk Management in Innovative Therapies 点播网络研讨会

    Pharmacovigilance and Risk Management in Innovative Therapies

    Pharmacovigilance2025年5月15日

    The webinar discusses the evolving pharmacovigilance and risk management environment of innovative therapies, emphasizing safety challenges in cell, CAR T, and RNA-based treatments, as well as gaps in regulation and surveillance strategies. Participants will gain insight into the origin and impact of safety concerns in these therapies, alongside ongoing developments in RNA-based treatments.

    立即观看

    我们使用 Cookie 来改善您的体验

    我们使用必要的 Cookie 来保证网站功能,以及可选的分析 Cookie 来改善我们的服务。 阅读我们的 隐私政策Cookie 政策.